Welcome to the ILCA Webinar Series On-Demand page. Here, you can access all of our past webinars covering a range of topics relevant to liver cancer treatment and care. Our on-demand webinars offer a flexible and convenient learning experience that allows you to access high-quality educational content at your convenience.
Systemic treatment for advanced HCC: How to choose and sequence systemic therapies for advanced HCC of moving immunotherapy for HCC into earlier scenarios/How to treat special populations
What’s the best approach to treating advanced HCC? In this webinar, Arndt Vogel, Anna Saborowski, Bernhard Scheiner and Katie Kelley explore how to choose and sequence therapies, emphasising treating special patient populations.
The complex goal of moving immunotherapy for HCC into earlier scenarios
What are the challenges and strategies for advancing immunotherapy in HCC to earlier treatment stages and improving patient outcomes?
In this webinar, co-chaired by Peter Galle and Marco Sanduzzi-Zamparelli, we discussed the latest advancements and clinical strategies in this rapidly evolving field.
Integrating Hepatocellular Carcinoma Therapies in Resource-Limited Settings
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Pediatric Liver Cancer
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
TACE plus Systemic Therapy: Ready to Use?
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Genome-based treatment of HCC resistant to treatment
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Updates in Liver Transplantation for Hepatocellular Carcinoma and Cholangiocarcinoma. What’s new in 2024?
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Advances in radiotherapy in hepatocellular carcinoma
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Digital pathology and multiomics age for biomarkers discovery in HCC
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Portal Hypertension Issues in Hepatocellular Carcinoma
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Update on Rare Primary Liver
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
LCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Immunotherapy for early intermediate HCC
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Screening and Treatment of Gastroesophageal Varices Prior to Systemic Therapy for HCC
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Deciphering NASH-HCC development and response to therapy
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Role of Microbiome in Liver Cancer
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Advances in surgical therapy for HCC
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Intrahepatic cholangiocarcinoma: novel epidemiology, diagnosis and treatment opportunities – in SPANISH
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Radioembolization of HCC in 2023
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
We regret to inform you that the webinar introduction is not included in the recording due to unforeseen technical difficulties beyond our control. We apologize for any inconvenience caused.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Clinical trial designs for the development of new drugs for liver cancer (HCC and CC)
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Liver transplant for CCA
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
New IO targets in liver cancer
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Targeted therapies and immunotherapy for unresectable BTC/CCA
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Benefits and risks of systemic therapy for patients with HCC awaiting liver transplantation
This webinar has taken place and is now available on demand. If you’re an ILCA member, you can access the webinar for free. For non-members, we offer access to the webinar for a fee of 40 euros.
ILCA Members: click here to access the webinar
Non-Members: click here to purchase the webinar
Novel emerging therapies for advanced HCC
Tuesday 13 December, 2022
In this webinar, our experts will discuss:
- Existing data and current developments on the combination of systemic and locoregional therapies in HCC
- Future therapeutic directions in HCC
Recommendations for practicing TACE
Tuesday 8 November, 2022
During this symposium, the latest role of TACE in the context of recent development of systemic therapy and the new data regarding TACE use will be discussed. Participants will hear more about new concepts on applying TACE in the treatment of HCC, on the maximization of TACE’s benefits in HCC patients and on the standardization in administering TACE in clinical practice and research. We will also present the ILCA TACE consensus and its clinical impact. Attendees will have the opportunity to learn key areas from experts in the field:
- Refinement of TACE to suitable population
- Standardization of TACE technique
- Consensus on the retreatment and stopping criteria of TACE
Recent developments in targeted therapies in BTC
Tuesday 11 October, 2022
During this webinar, current recommendations for molecular profiling in biliary tract tumours will be summarised, together with latest trial data supporting the use of targeted therapies strategies in this scenario. We will also have dedicated time to review and discuss ongoing challenges, not only for molecular profiling but also for the use of targeted therapies and how the future looks like in this setting.
Taking that next step: Tips on how to become an independent researcher and lead your own projects
Thursday 22 September, 2022
Hear from young stars in the field of liver cancer research as they share their career journeys to becoming independent. They will discuss topics including:
- How to lead your own projects and be the PI/senior author
- How to break free from being reliant on your supervisors
- Securing funding
- Finding your research niche
Tumor Heterogeneity in HCC analyzed by Single Cell Analysis
Thursday 16 June, 2022
Three experts in the liver cancer and single cell analysis came together and discussed latest research findings on:
- HCC and iCCA
- Immune cell interaction with hepatocytes
- Find out about the rest in the webinar…
Clinical Applications for Liquid Biopsy in Hepatocellular Carcinoma
Tuesday 10 May, 2022
During the webinar we learned more about the potential role of liquid biopsy across the spectrum of HCC, and topics including:
- What is liquid biopsy?
- The role of liquid biopsy for HCC detection
- and more to find out in on-demand webinar
Tips from the editor’s desk: How to succeed in the peer review process
Tuesday 12 April, 2022
5 Senior Editors from top journals in hepatology and oncology come together to discuss all aspects of the peer review process, including:
- How to be a good peer reviewer
- How to review revised manuscripts
- Formatting revised manuscripts and responses to reviewers
- Discussing questions around revisions or acceptance decisions with the editor
Neoadjuvant and Adjuvant Immunotherapy in HCC
Thursday 10 March, 2022
The use of immunotherapy in the treatment of cancer has rapidly increased and is approved to treat HCC in the advanced stage. This has led to a growing interest in their clinical use. This webinar summarises the current evidence and the gaps in knowledge.
- Rationale and surgical perspective
- Facts, Challenges, and future directives
Systemic Therapy for Advanced HCC Continues to Evolve Rapidly
Tuesday 8 February, 2022
- Durva Tremi: a new first-line option for advanced HCC?
- What is the future for combining checkpoint inhibitors and TKIs?
- What is the role for single agent TKI first-line?
Primary and acquired resistance to immunotherapy in HCC: From research to practice
Thursday 11 November, 2021
- How can animal models help better understand primary and secondary resistance to immune checkpoint inhibitor therapy
- Combination Strategies to Address Immune Checkpoint Inhibitor Resistance in Advanced HCC
- Insight from neoadjuvant and adjuvant trials of immunotherapy
Systemic therapy of CCA. Patho-molecular profile meets treatment choices
Monday 27 September, 2021
- Pathology of CCA
- Molecular characterization, actionable genetic alterations
- Targeted therapies including immunotherapy given recent promising early phase data with lenva-pembro or IO+chemo and ongoing phase 2-3 trials
Radiation oncology in the management of HCC. Who and how should be treated.
Thursday 17th June, 2021
Duration: 1 hour
Best of ILCA 2020
As 2021 gets into gear, ILCA’s liver cancer experts present this webinar based on key selected sessions of the ILCA 2020 Annual Conference.
Thursday 25th February, 2021
Duration: 1 hour
Management Of Hcc During Covid-19: ILCA Guidance
Our expert presenters discussed the current data on COVID-19-related liver disease and the impact of SARS-CoV-2 infection in patients with chronic liver diseases.
Friday 17th April, 2020
Duration: 1 hour